These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 445323)

  • 1. Solid tumor models for the assessment of different treatment modalities: VIII. The scheduling of treatment for a chemotherapeutically resistant experimental solid tumor.
    Looney WB; Hopkins HA; MacLeod MS
    Cancer; 1979 Apr; 43(4):1201-10. PubMed ID: 445323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid tumour models for the assessment of different treatment modalities: VII: single vs fractionated doses of 5-fluorouracil on two solid tumours and their hosts.
    Looney WB; Macleod MS; Hopkins HA
    Br J Cancer; 1978 May; 37(5):841-8. PubMed ID: 207298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid tumor models for the assessment of different treatment modalities. XIII. Comparison of response and recovery of host and solid tumor to cyclophosphamide and radiation.
    Looney WB; Hopkins HA; Grover WH; Macleod MS; Ritenour ER; Hobson AS
    Cancer; 1980 Jun; 45(11):2793-804. PubMed ID: 7379010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple drug chemotherapy combined with multiple fractions per day (MFD) radiotherapy in an experimental solid tumor model.
    Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
    In Vivo; 1994; 8(1):107-12. PubMed ID: 8054501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr).
    Drago JR; Goldman LB; Gershwin ME
    Cancer; 1980 Jul; 46(2):273-8. PubMed ID: 7388771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE; Young RC; Chabner BA
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
    Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
    Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems.
    Kallman RF; Rapacchietta D; Zaghloul MS
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):227-32. PubMed ID: 1991683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.
    Irwin LE; Chlebowski RT; Weiner JM; Reynolds R; Pugh RP; Ryden VM; Bateman JR
    Cancer Treat Rep; 1980; 64(8-9):981-4. PubMed ID: 7004635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of DNA synthesis as an indication of drug toxicity and as a guide for scheduling cancer therapy.
    Wheeler GP; Alexander JA
    Cancer Treat Rep; 1978 May; 62(5):755-69. PubMed ID: 657161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of different dosages of chemotherapeutic agents on survival of mice with ascitic tumor (author's transl)].
    Pepper I; Ortiz AE; Silva H
    Rev Med Chil; 1979 Jan; 107(1):1-5. PubMed ID: 462021
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid tumor models for the assessment of different treatment modalities. XIX. Tumor cure rates and tumor control following sequential administration of radiation and cyclophosphamide.
    Looney WB; Ritenour ER; Hopkins HA
    Am J Clin Oncol; 1982 Apr; 5(2):209-20. PubMed ID: 7091043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
    Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
    Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.
    Lelieveld P; Scoles MA; Brown JM; Kallman RF
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):111-21. PubMed ID: 4038500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
    Soloway MS
    Natl Cancer Inst Monogr; 1978 Dec; (49):327-32. PubMed ID: 748788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
    Calabresi F; Di Lauro L; Marolla P; Curcio CG; Paoletti G; Calabró A; Giannarelli D; Ballatore P; Foggi CM; Di Palma M
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):66-72. PubMed ID: 2031201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
    Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T
    Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.